BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 12.18
+0.23 (1.92%)
At close: Dec 5, 2025
BioSyent Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 16.57 | 12.11 | 7.98 | 7.86 | 18.04 | 20.29 | Upgrade
|
| Short-Term Investments | 6.83 | 3.83 | 18.2 | 20.83 | 10.18 | 5.29 | Upgrade
|
| Cash & Short-Term Investments | 23.4 | 15.94 | 26.19 | 28.7 | 28.21 | 25.58 | Upgrade
|
| Cash Growth | 37.10% | -39.13% | -8.74% | 1.72% | 10.30% | 16.40% | Upgrade
|
| Accounts Receivable | 6.22 | 2.87 | 3.45 | 3.18 | 2.49 | 1.6 | Upgrade
|
| Other Receivables | 0.05 | 0.03 | 0.03 | 0.32 | 0.29 | 0.22 | Upgrade
|
| Receivables | 6.33 | 2.99 | 3.55 | 3.66 | 3.21 | 1.82 | Upgrade
|
| Inventory | 5.9 | 5.33 | 5.89 | 4.54 | 2.2 | 2.07 | Upgrade
|
| Prepaid Expenses | 0.34 | 0.2 | 0.24 | 0.25 | 0.46 | 0.31 | Upgrade
|
| Other Current Assets | - | 0.01 | - | - | - | - | Upgrade
|
| Total Current Assets | 35.97 | 24.47 | 35.87 | 37.14 | 34.08 | 29.77 | Upgrade
|
| Property, Plant & Equipment | 1 | 1.16 | 1.4 | 1.61 | 1.85 | 2.07 | Upgrade
|
| Long-Term Investments | 5.4 | 10.1 | 2.5 | - | - | - | Upgrade
|
| Other Intangible Assets | 4.79 | 4.88 | 1.02 | 1.09 | 0.83 | 0.96 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.34 | 0.4 | 0.36 | 0.21 | 0.1 | 0.03 | Upgrade
|
| Long-Term Deferred Charges | 0.2 | 0.2 | 0.17 | 0.17 | 0.12 | 0.13 | Upgrade
|
| Total Assets | 47.79 | 41.36 | 41.53 | 40.49 | 37.17 | 33.57 | Upgrade
|
| Accounts Payable | 6.41 | 4 | 5.08 | 5.06 | 3.56 | 3.72 | Upgrade
|
| Current Portion of Leases | 0.21 | 0.2 | 0.18 | 0.17 | 0.16 | 0.15 | Upgrade
|
| Current Income Taxes Payable | 0.31 | 0.4 | 0.11 | 0.32 | 0.1 | 0.25 | Upgrade
|
| Current Unearned Revenue | 0.16 | 0.81 | 0.13 | 0.16 | 0.31 | 0.93 | Upgrade
|
| Other Current Liabilities | 0.02 | - | 0.03 | - | - | 0.08 | Upgrade
|
| Total Current Liabilities | 7.11 | 5.41 | 5.53 | 5.72 | 4.14 | 5.14 | Upgrade
|
| Long-Term Leases | 0.68 | 0.84 | 1.04 | 1.22 | 1.4 | 1.56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.09 | 0.11 | 0.2 | 0.18 | 0.08 | 0.08 | Upgrade
|
| Total Liabilities | 7.88 | 6.36 | 6.77 | 7.12 | 5.61 | 6.78 | Upgrade
|
| Common Stock | 5.24 | 5.31 | 5.12 | 5.37 | 5.8 | 6.39 | Upgrade
|
| Additional Paid-In Capital | 2.01 | 2.14 | 2.29 | 2.23 | 1.82 | 1.49 | Upgrade
|
| Retained Earnings | 32.82 | 27.73 | 27.53 | 25.91 | 24.12 | 19.08 | Upgrade
|
| Comprehensive Income & Other | -0.17 | -0.17 | -0.18 | -0.14 | -0.19 | -0.17 | Upgrade
|
| Shareholders' Equity | 39.9 | 35 | 34.76 | 33.36 | 31.55 | 26.8 | Upgrade
|
| Total Liabilities & Equity | 47.79 | 41.36 | 41.53 | 40.49 | 37.17 | 33.57 | Upgrade
|
| Total Debt | 0.89 | 1.04 | 1.22 | 1.4 | 1.56 | 1.71 | Upgrade
|
| Net Cash (Debt) | 22.5 | 14.9 | 24.97 | 27.3 | 26.65 | 23.87 | Upgrade
|
| Net Cash Growth | 40.81% | -40.31% | -8.55% | 2.42% | 11.67% | 18.63% | Upgrade
|
| Net Cash Per Share | 1.95 | 1.26 | 2.05 | 2.18 | 2.07 | 1.82 | Upgrade
|
| Filing Date Shares Outstanding | 11.26 | 11.26 | 11.61 | 12.1 | 12.41 | 12.74 | Upgrade
|
| Total Common Shares Outstanding | 11.26 | 11.28 | 11.74 | 12.1 | 12.56 | 12.81 | Upgrade
|
| Working Capital | 28.86 | 19.07 | 30.34 | 31.42 | 29.94 | 24.64 | Upgrade
|
| Book Value Per Share | 3.54 | 3.10 | 2.96 | 2.76 | 2.51 | 2.09 | Upgrade
|
| Tangible Book Value | 35.11 | 30.13 | 33.74 | 32.27 | 30.72 | 25.83 | Upgrade
|
| Tangible Book Value Per Share | 3.12 | 2.67 | 2.87 | 2.67 | 2.45 | 2.02 | Upgrade
|
| Machinery | 0.97 | 0.95 | 0.91 | 0.85 | 0.81 | 0.75 | Upgrade
|
| Leasehold Improvements | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.